Pretreatment prognostic factors for predict survival outcome in advanced non small cell lung cancer with first line treatment in Thailand. A retrospective cohort study
Not Applicable
Completed
- Conditions
- Focus on Pretreatment Factors that possible effect to survivalPretreatment factors,survival,Non Small Cell Lung Cancer
- Registration Number
- TCTR20161219003
- Lead Sponsor
- Faculty of medicine,Chulalongkorn university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 310
Inclusion Criteria
Non small cell lung cancer who the oncologists consider receive
treatment
2. Age ≥ 18 years
3. Definite diagnosis of NSCLC by histology, or cytology
4. Complete of laboratory investigation within1 week before starting
chemotherapy
5. Eastern Cooperative Oncology Group (ECOG) performance status of 0
to 2
Exclusion Criteria
Previous treatment of chemotherapy or chemo radiotherapy
2. Patients who have NSCLC as a new second primary cancer.
3. Patients who have history of any infection within 2 weeks before
chemotherapy
4. Patients who have history of chronic liver disease,or autoimmune
disease
9
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method event 3 years retrospective data survival
- Secondary Outcome Measures
Name Time Method Depression symptom score baseline, week4 and week12 HRDS score/ clinician rated,urine 8-isoprostane baseline, week4 and week12 EIA kit/ mg,urine melatonin baseline, week4 and week12 EIA kit/ mg,adverse event baseline, week4 and week12 Adverse effects symptom check list /self-rated .